1 Answers
Adult: 400 mg bid. May continue until patient shows unacceptable toxicity or evidence of progression.
Patient on strong CYP3A4 inhibitor: Reduce dose to 300 mg once daily, or to 200 mg once daily in newly-diagnosed chronic phase Philadelphia chronic myelogenous leukaemia. Dose may be adjusted to usual dose after a washout period.
Patient on drugs that prolong QT interval (e.g. antiarrhythmics): Reduce dose and closely monitor for QT interval prolongation.
Hepatic Impairment: Use a lower starting dose.
Should be taken on an empty stomach. Avoid food at least 2 hr before & at least 1 hr after a dose. Swallow whole, do not chew/crush. Avoid grapefruit products.
টাসিগনা ক্যাপসুল সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে টাসিগনা